Our Mission:

Empowering Scientists to Solve Our Greatest Challenges.

Our Services

Custom solutions for R&D, product development and small-scale manufacturing

Engineering Design

Design sensors, biosensors, electrodes and microfluidic templates

Metal Coatings

Deposition of thin films of gold, platinum, silver, aluminum, copper and more.

Surface Patterning

Fabricate devices via photolithography, wet etching and lift-off.

Cutting and Dicing

Discover our capabilities for device singulation.

Fluid Dispensing

Precision dispensing of fluid droplets and fluid films.


Discover our extensive capabilities for quality control including electrical and optical testing

Heat Treatment

Learn about high-temperature processing.

Cleaning & Etching

Read about dry, wet, and ultrasonic surface treatments.

Our Vision:

Leverage Surface Science to accelerate the commercialization of new technologies

Custom Solutions by Platypus Technologies

Have a special project in mind? We can help! Our team has extensive experience creating biosensors, chemical sensors, microfluidic devices, and more.

Learn More


The Latest From Platypus Technologies

Unlocking Alzheimer’s Molecular Secrets with Infrared Nanospectroscopy

Alzheimer’s disease is a devastating condition characterized by memory loss and cognitive impairment, causing immense suffering for patients and their families. One of the main causes of Alzheimer’s is the aggregation of a protein called amyloid-β (Aβ42) in the brain, leading to the formation of toxic structures. Scientists have been working tirelessly to understand the molecular basis of this disorder and develop treatments that can stop or reverse the aggregation process. In a groundbreaking study, researchers used infrared nanospectroscopy and ultra-flat gold to explore the interactions between Aβ42 aggregates and a small molecule inhibitor.

Read More

Unveiling the Secrets of Alzheimer’s Disease at the Nanoscale

Alzheimer’s disease (AD) is a debilitating neurodegenerative condition that affects millions of people worldwide. It is the leading cause of cognitive decline and death among seniors, accounting for about 70% of all neurodegenerative diseases. One of the hallmarks of AD is the accumulation of amyloid-β (Aβ) proteins, which form toxic aggregates known as amyloid plaques. To better understand the molecular mechanisms behind AD and develop effective treatments, researchers are continually exploring new techniques to study these proteins at the nanoscale.

Read More